Current therapeutics : XXIX, 1, 2026
[Trattamento enzimatico sostitutivo con velmanase alfa in pazienti affetti da alfa-mannosidosi : volume 2]
Fait partie de
Current therapeutics. - Mensile = MonthlyVoir les conditions d’utilisation
PDF
Fascicule
Fascicule
Current therapeutics : XXIX, 3, 2026
[Complications and Management of Hyaluronic Acid Fillers : a Narrative Review with Case Reports]
Fait partie de
Current therapeutics. - Mensile = MonthlyVoir les conditions d’utilisation
PDF
Fascicule
Fascicule
Current therapeutics : XXVIII, 5, 2025
[Trattamento enzimatico sostitutivo con velmanase alfa in pazienti affetti da alfa-mannosidosi]
Fait partie de
Current therapeutics. - Mensile = MonthlyVoir les conditions d’utilisation
PDF
Fascicule
Fascicule
Current therapeutics : XXVIII, 3, 2025
[Therapeutic use of Polynucleotides HPT in osteoarthritis : the weight of evidence]
Fait partie de
Current therapeutics. - Mensile = MonthlyVoir les conditions d’utilisation
PDF
Fascicule
Fascicule
Therapy perspectives : for rational drug use & disease management : XXVI, 4, 2023
[Trientine formulations : pharmacological insights for a clinical perspective]
Fait partie de
Therapy perspectives : for rational drug use & disease management. - Trimestrale = Three-monthlyVoir les conditions d’utilisation
PDF
Fascicule
Fascicule
page 1 of 1